210 related articles for article (PubMed ID: 18573234)
1. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.
Kojima K; Ohhashi R; Fujita Y; Hamada N; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Aug; 373(3):423-8. PubMed ID: 18573234
[TBL] [Abstract][Full Text] [Related]
2. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
Wang TT; Schoene NW; Kim EK; Kim YS
Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
[TBL] [Abstract][Full Text] [Related]
4. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
5. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.
Akao Y; Banno Y; Nakagawa Y; Hasegawa N; Kim TJ; Murate T; Igarashi Y; Nozawa Y
Biochem Biophys Res Commun; 2006 Apr; 342(4):1284-90. PubMed ID: 16516161
[TBL] [Abstract][Full Text] [Related]
6. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 is significantly elevated in mouse and human prostate cancer.
Huffman DM; Grizzle WE; Bamman MM; Kim JS; Eltoum IA; Elgavish A; Nagy TR
Cancer Res; 2007 Jul; 67(14):6612-8. PubMed ID: 17638871
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of apoptosis induced by SIRT1 deacetylase inhibitors in human breast cancer MCF-7 drug-resistant cells].
Li Y; Xu R; Zhang XM; Li DD; He QY
Yao Xue Xue Bao; 2008 Oct; 43(10):1003-10. PubMed ID: 19127863
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 modulates premature senescence-like phenotype in human endothelial cells.
Ota H; Akishita M; Eto M; Iijima K; Kaneki M; Ouchi Y
J Mol Cell Cardiol; 2007 Nov; 43(5):571-9. PubMed ID: 17916362
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate.
Janssen T; Darro F; Petein M; Raviv G; Pasteels JL; Kiss R; Schulman CC
Cancer; 1996 Jan; 77(1):144-9. PubMed ID: 8630922
[TBL] [Abstract][Full Text] [Related]
12. The critical role of the class III histone deacetylase SIRT1 in cancer.
Liu T; Liu PY; Marshall GM
Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
Ford J; Jiang M; Milner J
Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation is involved in chemoresistance induced by EGF in prostate cancer cells.
Li Y; Chen HQ; Chen MF; Liu HZ; Dai YQ; Lv H; Bing Zu X; Qi L
Life Sci; 2009 Jun; 84(25-26):882-7. PubMed ID: 19356736
[TBL] [Abstract][Full Text] [Related]
15. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?
Jung-Hynes B; Nihal M; Zhong W; Ahmad N
J Biol Chem; 2009 Feb; 284(6):3823-32. PubMed ID: 19075016
[TBL] [Abstract][Full Text] [Related]
16. Function of the SIRT1 protein deacetylase in cancer.
Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
[TBL] [Abstract][Full Text] [Related]
17. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors.
Suzuki T; Imai K; Imai E; Iida S; Ueda R; Tsumoto H; Nakagawa H; Miyata N
Bioorg Med Chem; 2009 Aug; 17(16):5900-5. PubMed ID: 19616958
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
20. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells.
Matsushita N; Takami Y; Kimura M; Tachiiri S; Ishiai M; Nakayama T; Takata M
Genes Cells; 2005 Apr; 10(4):321-32. PubMed ID: 15773895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
